The administration of PD-L1 and Gal-9 EVs to recent-onset T1D NOD mice reduced the proportion of IFNγ+ and TNFα+ CD8+ T cells and increased the proportion of Foxp3+ Treg cells in the pancreas. Here, CD8A is linked to type 1 diabetes mellitus.